NAFLD in diabetes: Screening and preventive strategies
Year: 2024
Type: article
Abstract: Dear Sir, I came across this study “Prevalence of nonalcoholic fatty liver disease among diabetes, prediabetes, and healthy population [11(12):p 7640–7643, December 2022]” which is well written. It has explained the disease and prevalence in detail well.[1] The prevalence of nonalcoholic fatty liver disease (NAFLD) in diabetes is increasing daily. Given that diabetes has grown to be a major global health concern, early nonalcoholic fatty liver disease detection and treatment are crucial. To identify those who are at a high risk of developing nonalcoholic fatty liver disease, we should also concentrate on screening them. The tactics and preventive measures to avoid the disease in a study population ought to have been more detailed, in my opinion. As liver biopsy is invasive, not all patients find it acceptable for diagnosing nonalcoholic fatty liver disease (NAFLD). Nevertheless, it is the gold standard for diagnosis. Ultrasonography is a noninvasive technique that has demonstrated good patient compliance and can be used to diagnose fatty liver, according to research, and hence can be implemented in the screening.[2] Since it is well recognized that changing one’s lifestyle can help avoid noncommunicable diseases, it would have been beneficial if you could have provided more details about the tactics and precautions involved. Exercise, yoga, physical activity of any kind, and good eating practices are examples of lifestyle adjustment techniques that should continue to be everyone’s major priority. It is possible to raise knowledge about the condition and its prevention through health talk sessions and camps, as the majority of patients are discovered by accident. It would be preferable if diabetics receiving care in the National Programme for Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases, and Stroke Corners which are generally accessible provided information about the nonalcoholic fatty liver disease through various IEC materials. According to recent studies, India now has a higher prevalence of diabetes patients than China. It is highly alarming that the prevalence is rising and that this may have significant effects on public health for a larger population. Thus, it is expected that the prevalence of nonalcoholic fatty liver disease would contribute to the burden of chronic liver disease, especially in India where the number of diabetics is increasing. Hence, it mandates immediate action to prevent nonalcoholic fatty liver disease from becoming a major public health burden. Financial support and sponsorship Nil. Conflicts of interest There are no conflicts of interest.
Authors: Isha Mohan Patole, Sheeza Shaikh
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $450
OpenAlex ID: W4402403195